Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Cervical Cancer Market Global Briefing 2017

Cervical Cancer Market Global Briefing 2017

From $1,000.00

Including: Chemotherapy, Targeted Therapy, Vaccines And Hormone Therapy.
Covering: Hetero, GlaxoSmithKline, Eli Lilly, Pfizer, Novartis


Clear selection
SKU: 2264. Category: .
Description

Cervical Cancer Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cervical cancer market.

Description

The Cervical Cancer Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The cervical cancer market is one of the segments in the oncology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the cervical cancer market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the cervical cancer market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the cervical cancer market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Chemotherapy, Targeted Therapy, Vaccines and Hormone Therapy.

Companies Mentioned: Hetero, GlaxoSmithKline, Eli Lilly, Pfizer, Novartis.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Lung cancer Market Global Briefing 2017
Pancreatic cancer Market Global Briefing 2017
Breast cancer Market Global Briefing 2017
Prostate cancer Market Global Briefing 2017
Ovarian cancer Market Global Briefing 2017
Gastric Cancer Market Global Briefing 2017
Non-Small Cell Lung Cancer Market Global Briefing 2017
Brain Tumor Market Global Briefing 2017
Colorectal Cancer Market Global Briefing 2017
Thyroid cancer Market Global Briefing 2017
Bladder Cancer Market Global Briefing 2017
Kidney Cancer Market Global Briefing 2017
Skin cancer Market Global Briefing 2017
Blood cancer Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Cervical Cancer Market Characteristics
3. Cervical Cancer Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Cervical Cancer Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Cervical Cancer Market Geography Split
6. Cervical Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
7. Cervical Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
8. Cervical Cancer Market Segmentation
9. Cervical Cancer Competitive Landscape
Hetero
GlaxoSmithKline
Eli Lilly
Pfizer
Novartis
10. Key Mergers And Acquisitions In The Cervical Cancer Market
11. Cervical Cancer Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Cervical Cancer Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Cervical Cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Cervical Cancer Market, Split By Region, 2016, $ Billion
Table 4: Cervical Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Table 5: Cervical Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
Table 6: Global Cervical Cancer Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Cervical Cancer Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Cervical Cancer Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Cervical Cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Cervical Cancer Market, Split By Region, 2016, $ Billion
Figure 4: Cervical Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Figure 5: Cervical Cancer Market As A Proportion of Oncology Drugs Market, 2020, By Country
Figure 6: Global Cervical Cancer Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Cervical Cancer Market, Split By Segments, 2016, $ Billion
Executive Summary
The cervical cancer drugs market covers drugs that treat cancer that affect the tissues of the cervix. The indications include squamous cell carcinomas, metastatic cervical cancer, and adenocarcinomas. Some of the major drugs in this market are Topotecan Hydrochloride, Hycamtin (Topotecan Hydrochloride), Bleomycin, Blenoxane (Bleomycin), Bevacizumab, Avastin (Bevacizumab), Gardasil, and Cervarix. Based on the prevention and treatment type, cervical cancer drugs market is segmented into four major segments: chemotherapy, targeted therapy, vaccines and hormone therapy.

The global cervical cancer market was estimated to be around $13.06 billion as of 2016. The global cervical cancer made up around 11% of the overall oncology drugs market in 2016. The cervical cancer market was the third largest market in the global oncology drugs market in 2016.

Regulatory Approvals
Continous approvals from regulatory bodies such as FDA in the US and EMA in Europe is one of the major trend in this market. For instance, in December 2014, Merck received FDA approval for its GARDASIL that is used to prevent cervical, vulvar, vaginal, and anal cancers. Through this approval, Merck focuses on strengthening its market position in the US cervical cancer drugs market. In October 2016, Merck received FDA approval for its 2-dose vaccination regimen for GARDASIL 9 drug. This drug is used for the prevention of cervical, vulvar, vaginal, and anal cancers caused by HPV.
Get Customized Report
Please fill in your details. Our team will get back to you